Lawmakers Challenge Proposed Changes to NIH Grant Processes

A group of House Democrats is urging the Trump administration to rescind a new proposal that could significantly alter the federal grantmaking process for the National Institutes of Health (NIH), potentially impacting scientific research.

Concerns Over Political Influence

The proposal aims to exert more political control over NIH research by reducing the role of scientific experts in grant approval and funding decisions. Democrats on the House Energy and Commerce Committee, including Rep. Frank Pallone Jr. (D-N.J.), Rep. Diana DeGette (D-Colo.), and Rep. Yvette Clarke (D-N.Y.), expressed concerns that the changes could harm biomedical research and lead to fewer clinical trials and exposure to public health risks.

The damage caused by this power grab threatens the nation’s biomedical research enterprise.

The proposed rule, introduced quietly by the administration, would reduce the emphasis on peer review and allow political appointees to decide research priorities that align with presidential policies. Research on themes like diversity, equity, and inclusion would be excluded from grant conditions, and international collaborations would face restrictions.

Political Partisanship Concerns

Democrats have criticized the proposed rule for potentially introducing unprecedented partisanship into NIH’s decision-making processes. They argue this could align spending with political preferences over scientific merit. The White House claims the rule is needed to enhance transparency and reduce waste, fraud, and abuse.

The proposal, issued by the Office of Management and Budget (OMB) under Director Russell Vought, faces opposition from lawmakers demanding its repeal. While Congress, controlled by Republicans, may have limited ability to intervene, potential legal challenges loom if the rule is enacted.

Other Health News

• A major influenza outbreak affects over 220 troops at Lackland Air Force Base in Texas, following a policy change by Defense Secretary Pete Hegseth making flu vaccinations non-mandatory.
• The FDA announced a new pilot program to accelerate early-stage clinical trials, part of ‘Operation Trailblazer’ aiming to reduce development timelines and encourage domestic research over foreign relocation.
• Congo reports more than 1,000 cases of Ebola, with concerns about virus spread in displacement camps housing tens of thousands.

For more updates on healthcare policies and implications, sign up for The Hill’s Health Care newsletter.